These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2701587)

  • 21. Primary and secondary prevention of cardiovascular disease in the elderly.
    García-Palmieri MR
    Bol Asoc Med P R; 2000; 92(1-3):3-8. PubMed ID: 10846280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spectacular advances in cardiology: molecular biology promises more to come. Interview by Robert Henry].
    Bourassa M
    Union Med Can; 1992; 121(3):150-6. PubMed ID: 1615561
    [No Abstract]   [Full Text] [Related]  

  • 23. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view.
    Zweig S
    J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527
    [No Abstract]   [Full Text] [Related]  

  • 24. [The new debate on cholesterol: is the lowest level the best?].
    Olsson AG
    Lakartidningen; 1999 Feb; 96(6):648-52. PubMed ID: 10087815
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pravastatin multicenter clinical trial in patients with hypercholesterolemia and multiple risk factors].
    Barrett e Pesquisadores AC
    Arq Bras Cardiol; 1997 Jan; 68(1):65-71. PubMed ID: 9334463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiology of coronary disease: a review of the literature].
    Paradis GB; Battista RN; Miranda PS; Spitzer WO; Tremblay J
    Union Med Can; 1985 Mar; 114(3):190-8. PubMed ID: 3890313
    [No Abstract]   [Full Text] [Related]  

  • 27. High cholesterol levels in healthy seniors: cause for concern?
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(1):40-1. PubMed ID: 7770441
    [No Abstract]   [Full Text] [Related]  

  • 28. [Risk factors in coronary arteriosclerosis in women].
    Légeret MJ; Darioli R; Grandjean T; Gersbach P; Essinger A; Marazzi A
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1850-3. PubMed ID: 6676937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Broader indication for treatment with statins; the 'heart protection study'].
    Stalenhoef AF; Stuyt PM
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1921-3. PubMed ID: 12404905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

  • 33. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 34. Revisiting Rose: strategies for reducing coronary heart disease.
    Manuel DG; Lim J; Tanuseputro P; Anderson GM; Alter DA; Laupacis A; Mustard CA
    BMJ; 2006 Mar; 332(7542):659-62. PubMed ID: 16543339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypercholesterolemia: to treat or not to treat? That is the question].
    Ducobu J
    Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current developments in prevention of coronary heart disease].
    Windler E
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
    Guptha S
    Curr Opin Lipidol; 1995 Oct; 6(5):251-3. PubMed ID: 8520845
    [No Abstract]   [Full Text] [Related]  

  • 38. [The relationship between the extent of coronary artery disease and correlative risk factors in young men].
    Horiuchi K; Mizuno K; Shibuya T; Arakawa K; Satomura K; Isojima K; Ohsuzu F; Aosaki N; Kurita A; Nakamura H
    Kokyu To Junkan; 1985 Jun; 33(6):765-9. PubMed ID: 4035101
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dichotomy between cholesterol-lowering drugs in clinical trials and practice. Experience of the DiSCO Project (District of Serra Community Control of Chronic Degenerative Diseases)].
    Volpe R; Angelico F; Ricci G; Urbinati G
    Cardiologia; 1997 Aug; 42(8):815-25. PubMed ID: 9312408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.